Torthaí cuardaigh - Vivek Abraham

  • 1 - 2 toradh as 2 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    Marizomib activity as a single agent in malignant gliomas: ability to cross the blood-brain barrier

    Marizomib activity as a single agent in malignant gliomas: ability to cross the blood-brain barrier de réir Kaijun Di, G. Kenneth Lloyd, Vivek Abraham, Ann MacLaren, Francis Burrows, Annick Desjardins, Mohit Trikha, Daniela A. Bota

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    The Bcl-2/Bcl-XL/Bcl-w Inhibitor, Navitoclax, Enhances the Activity of Chemotherapeutic Agents <i>In Vitro</i> and <i>In Vivo</i>

    The Bcl-2/Bcl-XL/Bcl-w Inhibitor, Navitoclax, Enhances the Activity of Chemotherapeutic Agents <i>In Vitro</i> and <i>In Vivo</i> de réir Jun Chen, Sha Jin, Vivek Abraham, Xiaoli Huang, Bernard A. Liu, Michael J. Mitten, Paul Nimmer, Xiaoyu Lin, Morey L. Smith, Yu Shen, Alexander R. Shoemaker, Stephen K. Tahir, Haichao Zhang, Scott Ackler, Saul H. Rosenberg, Heather Maecker, Deepak Sampath, Joel D. Leverson, Chris Tse, Steven W. Elmore

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: